Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

8.3%

4 terminated out of 48 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

33%

16 trials in Phase 3/4

Results Transparency

11%

2 of 18 completed with results

Key Signals

2 with results82% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (10)
P 1 (2)
P 2 (1)
P 3 (6)
P 4 (10)

Trial Status

Completed18
Unknown11
Recruiting8
Not Yet Recruiting5
Terminated4
Withdrawn1

Trial Success Rate

81.8%

Benchmark: 86.6%

Based on 18 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT07753577Not Yet Recruiting

Clinical Trial to Evaluate the Effectiveness of Liver Shear Wave Quantization Detector Spleen Stiffness Value in the Diagnosis of Esophageal Varices

NCT07587671Not ApplicableNot Yet Recruiting

Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis

NCT07571876Not Yet Recruiting

Ultrasound Prediction of Esophageal Variceal Bleeding Risk

NCT07502729Not Yet Recruiting

Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

NCT07464522Not Yet RecruitingPrimary

Non-invasive Predictors of Esophageal Varices and Their Correlation to Upper Endoscopic Findings

NCT06017102Not ApplicableCompletedPrimary

Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices

NCT07122622Recruiting

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

NCT03624517Phase 4TerminatedPrimary

Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices

NCT07163689Recruiting

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

NCT05979935Active Not RecruitingPrimary

A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis

NCT06970509RecruitingPrimary

Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension

NCT06908798RecruitingPrimary

Fecal Calprotectin for Prediction of Esophageal Varices in Cirrhotic Patients

NCT06881082Not ApplicableRecruitingPrimary

Cross-section Band Ligation Versus Stepladder Band Ligation of Esophageal Varices

NCT06594744Phase 4Recruiting

Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC

NCT06594783Phase 4Recruiting

Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders

NCT06214234Not ApplicableUnknownPrimary

Upper Endoscopy in Cirrhotic Patients With Upper Gastrointestinal Bleeding

NCT05485714CompletedPrimary

Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis

NCT06082219UnknownPrimary

Ulcer Bleeding After Band Ligation of Esophageal Varices

NCT03748563Not ApplicableCompleted

Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

NCT05781828UnknownPrimary

Noninvasive Methods For Prediction of Esophageal Varices in Children

Scroll to load more

Research Network

Activity Timeline